Diabetes, Heart and Cardiovascular Diseases News Chronicle Diabetes, Cardiovascular and Heart Diseases. Article 168
Published on April 20, 2017 at 08:30 AM GMT


Increased Risk Of Cardiac Arrest With NSAIDs Drugs

Emergency health condition cardiac arrest with nonsteroidal antiinflammatory painkiller drug NSAID. A study done by researchers from Denmark shows non-steroidal anti-inflammatory painkiller drugs (NSAIDs) are associated with increased risk to emergency health condition and fatal cardiac arrest. The investigators studied data of 28,947 Danish patients who had out of hospital cardiac arrest between 2001 and 2010. Investigators found 3,376 patients out 28,947 patients were treated with NSAID drugs a month before. Their study shows increased risk to incidents of out of hospital cardiac arrest with the following drugs.

Researchers called for tighter control in the usage of NSAIDs and they should be used with caution. They also advise patients with cardiovascular diseases and with disease risk factors to avoid using NSAIDs. The investigators says usage of NSAIDs worsens factors associated with cardiovascular disease such as

Lead author of the study is Professor Gunnar Gislason, a heart expert from Copenhagen University Hospital and the study findings were reported in the European Heart Journal - Cardiovascular Pharmacotherapy.


       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Wearable Technology For Elder Care
2. About Meizus H1 Wearable Device
3. About Esysta device
4. Wearable Device To Alleviate Stress and Anxiety
5. Only Heart Disease Risk Patients Will Be Benefited With Omega-3 Fish Oil Supplements

Cardiac arrest : A heart condition that arises when heart suddenly stops pumping blood.

 

Toujeo Lowers Hypoglycemia Events Among Insulin Dependent Type 2 Diabetes Patients

Sanofi make Toujeo Glargine lower hypoglycemia events in insulin dependent type 2 diabetes patient. Sanofi makes Toujeo insulin (also known as glargine). Toujeo drug was approved in UK during early 2015. It is an once-daily long acting insulin for type ii diabetes (T2D) patients and has the ability to control blood sugar levels beyond 24 hours if patient takes the drug daily and at the same time. The DELIVER 2 study, an observational study was conducted involving 1,894 people with type 2 diabetes (T2D) to test the effectiveness of Toujeo insulin for 6 months period when compared with other basal insulins. The observational study shows


       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Trials With Toujeo
2. Hypoglycemia & HbA1c. Approval Of Diabetes Drug Xultophy Liraglutide From Novo Nordisk
3. Risks To Severe Hypoglycemia
4. Increase In Diabetes And Insulin Resistance With Climate Change
5. Insulin Dependant Diabetes May Raise Stroke Risk

 

Wearable Contact Lenses To Measure Blood Sugar Levels
Biosensor contact lense to monitor blood sugar glucose level with tears in type 1 diabetes patients. Health care professionals advise type 1 diabetes (T1D) patients to test their blood sugar levels for 4 to 8 times in a day. Testing blood sugar levels for so many times daily can be very stressful and painful. To overcome the problem, researchers from the Oregon State University are developing an innovative contact lenses to measure and monitor blood sugar levels with tears. Researchers are using a transparent biosensor that can be integrated with the contact lenses to measure glucose levels. With this information, a patient can easily self administer insulin injection. The device can pass signal to the wearable insulin pumps too. Leader of the study is Gregory Herman from the Oregon State University.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Wearable Devices Market
2. Chameleon Wearable Fitness Tracker From Adidas
3. Death Risk With Low Blood Sugar Levels
4. Risks To Dementia With Blood Sugar Levels
5. Wearable Belt Type Medical Device To Treat Diabetes In Obese Individuals

 

Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.